Aripiprazole
Aripiprazole is an atypical antipsychotic primarily used to treat schizophrenia and bipolar disorder. It acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and as an antagonist at serotonin 5-HT2A receptors. Its relevance to longevity and health optimization is mainly through its potential cognitive-enhancing effects and mood stabilization, which can contribute to improved mental health and quality of life.
Member access required
Clinical protocols and outcomes data are available to AXIFI Members and Providers.